Algernon Pharmaceuticals Appoints Novotech as CRO for First ... - Nasdaq

--Algernon Pharmaceuticals Inc., a clinical stage pharmaceutical development company, is pleased to announce that it has appointed Novotech as the contract research organization for the Company ... Read More

Novotech and ObvioHealth are finalists for th | EurekAlert!

News Release 1-Oct-2021 Novotech and ObvioHealth are finalists for the Clinical Partnership of the Year Citeline Award 2021 ... Read More

Novotech Releases Hepatitis B Global Clinical Trial Landscape Report ...

Novotech is the global leader in hepatitis B research, having supported 90 Hepatitis B trials and counting, initiating 340+ sites and enrolling 5,000+ participants across all trial phases ... Read More

Novotech Chairs BioCentury Summit Workshop on | EurekAlert!

Novotech, the leading Asia Pacific biotech specialist CRO, is sponsoring BioCentury-BayHelix East-West Summit 2022, and Novotech’s Chief Commercial Officer Barry Murphy is Session Chair for the ... Read More

Novotech Honored with Frost & Sullivan’s 2024 Best ... - Morningstar

Recognition of Excellence Frost & Sullivan first recognized Novotech with their award for best APAC CRO in 2006, and Novotech has continued to win this award every year since. Read More

Novotech Releases New Biotech Industry Report with GlobalData and ...

SAN FRANCISCO, Feb. 24, 2021 /PRNewswire/ -- Novotech, the leading Asia-Pacific biotech specialist CRO and OCT West Coast sponsor, has just released new data reports for biotechs planning clinical ... Read More

Novotech Honored with Triple Win in 2025 Pharmaceutical Technology ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory partner for biotech and small- to mid-sized pharmaceutical companies, is proud to announce ... Read More

Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports ...

Novotech Releases In-Depth 2023 Global Clinical Trial Landscape Reports on Hemophilia and Primary Biliary Cholangitis BOSTON, Nov. 02, 2023 (GLOBE NEWSWIRE) -- Novotech, the leading Asia Pacific ... Read More

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary ...

Partnering with Novotech for IPF Clinical Trials With extensive expertise in pulmonary and respiratory diseases, Novotech offers biotech and pharmaceutical partners an accelerated path to market. Read More

Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary ...

Novotech Novotech Identifies Strategic Opportunities in Idiopathic Pulmonary Fibrosis Trials with Release of Global Market Insights Tuesday, April 22, 2025 10:15AM IST (4:45AM GMT) ... Read More